Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone

2016 ASCO Annual Meeting

Published: 5 Jun 2016

Views: 2574

Rating:

Save

Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA

Dr Goss presents at ASCO 2016, a Randomised Phase III Open Label Trial which looked at extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.

Read the news story for more.

Related Videos

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos

The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )

Insights into germline genetic screening of breast cancer patients

Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura

Insights into germline genetic screening of breast cancer patients ( Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Multiple myeloma In Rwanda: The need for further research

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )

GIST tumours and soft tissue sarcomas

Dr Atif Hussein - Memorial Cancer Institute, Miami, USA

GIST tumours and soft tissue sarcomas ( Dr Atif Hussein - Memorial Cancer Institute, Miami, USA )

Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam

Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute

The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam ( Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute )

More from ecancer